These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Surgical approach to posthepatitic cirrhotic patient today]. Meriggi F; Forni E G Chir; 1996; 17(6-7):370-8. PubMed ID: 9272983 [TBL] [Abstract][Full Text] [Related]
44. [Effect of transjugular intrahepatic portosystemic shunt for variceal bleeding in hepatocellular carcinoma patients with portal vein thrombosis]. Chung WJ; Jang BK; Park KS; Cho KB; Hwang JS; Ahn SH; Kim YH; Kim YH; Kim YJ Korean J Hepatol; 2005 Jun; 11(2):157-63. PubMed ID: 15980674 [TBL] [Abstract][Full Text] [Related]
45. Variceal bleeding and portal hypertension: much to learn, much to explore. Bhasin DK; Malhi NJ Endoscopy; 2002 Feb; 34(2):119-28. PubMed ID: 11822007 [TBL] [Abstract][Full Text] [Related]
46. [Prevention of variceal rebleeding by TIPS combined with embolization of gastric coronary veins: a clinical controlled study]. Wei B; Chen S; Li X; Tang CW Zhonghua Gan Zang Bing Za Zhi; 2011 Jul; 19(7):494-7. PubMed ID: 22152238 [TBL] [Abstract][Full Text] [Related]
47. Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Mahadeva S; Bellamy MC; Kessel D; Davies MH; Millson CE Am J Gastroenterol; 2003 Dec; 98(12):2688-93. PubMed ID: 14687818 [TBL] [Abstract][Full Text] [Related]
48. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Cello JP; Ring EJ; Olcott EW; Koch J; Gordon R; Sandhu J; Morgan DR; Ostroff JW; Rockey DC; Bacchetti P; LaBerge J; Lake JR; Somberg K; Doherty C; Davila M; McQuaid K; Wall SD Ann Intern Med; 1997 Jun; 126(11):858-65. PubMed ID: 9163286 [TBL] [Abstract][Full Text] [Related]
49. [Therapeutic endoscopy in portal hypertension. When, how and how far in 1998]. Ballesteros Amozurrutia MA Rev Gastroenterol Mex; 1998; 63(4 Suppl 1):S7-20. PubMed ID: 10068721 [TBL] [Abstract][Full Text] [Related]
50. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed. Membreno F; Baez AL; Pandula R; Walser E; Lau DT J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494 [TBL] [Abstract][Full Text] [Related]
51. Transjugular intrahepatic portosystemic shunt vs endoscopic therapy in preventing variceal rebleeding. Xue H; Zhang M; Pang JX; Yan F; Li YC; Lv LS; Yuan J; Palikhe M; Li WZ; Wang ZL World J Gastroenterol; 2012 Dec; 18(48):7341-7. PubMed ID: 23326143 [TBL] [Abstract][Full Text] [Related]
52. Endoscopic treatment of oesophageal varices. Krige JE; Bornman PC S Afr J Surg; 2000 Dec; 38(4):82-8. PubMed ID: 11424860 [TBL] [Abstract][Full Text] [Related]
53. Prevention of recurrent esophageal variceal hemorrhage: review and current recommendations. Kravetz D J Clin Gastroenterol; 2007; 41 Suppl 3():S318-22. PubMed ID: 17975483 [TBL] [Abstract][Full Text] [Related]
54. Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding. Tesdal IK; Filser T; Weiss C; Holm E; Dueber C; Jaschke W Radiology; 2005 Jul; 236(1):360-7. PubMed ID: 15955858 [TBL] [Abstract][Full Text] [Related]
55. How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts. Rössle M; Siegerstetter V; Olschewski M; Ochs A; Berger E; Haag K Am J Gastroenterol; 2001 Dec; 96(12):3379-83. PubMed ID: 11774952 [TBL] [Abstract][Full Text] [Related]